Phase III Trial Comparing a Defined Duration of Therapy Versus Continuous Therapy Followed by Second-Line Therapy in Advanced-Stage IIIB/IV Non-Small-Cell Lung Cancer

Authors:
  • MSMichael J. Schell
    Michael J. Schell
  • APAmy Peterman
    Amy Peterman
  • KBKamal Bakri
    Kamal Bakri
  • SYSteven Yates
    Steven Yates
  • RGRobert Gitten
    Robert Gitten
  • PUPaul Unger
    Paul Unger
  • JLJoanna Lee
    Joanna Lee
  • JLJi-Hyun Lee
    Ji-Hyun Lee
  • MTMaureen Tynan
    Maureen Tynan
  • MMMartha Moore
    Martha Moore
  • MKMerrill S. Kies
    Merrill S. Kies
Publisher website
Google Scholar
Abstract
PURPOSE: To compare four cycles of therapy versus continuous therapy to determine the optimal duration of chemotherapy in advanced non–small-cell lung cancer (NSCLC).